FOUNDING TEAM

RAPHAËL G. OGNAR, MSC, MBA

CEO & CO-FOUNDER

Pharma/Biotech executive with 24 years of commercial, drug development, product lifecycle, and strategy expertise. Throughout his career, he developed extensive expertise in Oncology/Hematology, Immuno-Oncology, and Cell Therapy, thanks to his recognized leadership skills in strategy and operations.

Besides fighting cancer, his passions are vintage wines, playing music in his family band, pushing himself rock climbing with his wife, and traveling the world with friends and family.

Raphaël owns a Master and a D.E.A. of Physiology and Neurosciences from the University of Bordeaux I&II and a Masters of Business Administration in Strategic Marketing and Enterprise Management from I.A.E of Tours University.

RAPHAËL G. OGNAR, MSC, MBA

CEO & CO-FOUNDER

Pharma/Biotech executive with 24 years of commercial, drug development, product lifecycle, and strategy expertise. Throughout his career, he developed extensive expertise in Oncology/Hematology, Immuno-Oncology, and Cell Therapy, thanks to his recognized leadership skills in strategy and operations.

Besides fighting cancer, his passions are vintage wines, playing music in his family band, pushing himself rock climbing with his wife, and traveling the world with friends and family.

Raphaël owns a Master and a D.E.A. of Physiology and Neurosciences from the University of Bordeaux I&II and a Masters of Business Administration in Strategic Marketing and Enterprise Management from I.A.E of Tours University.

HENRI BAYLE, PHD

CTO/CDO & CO-FOUNDER

Hank has extensive experience in the development of new approaches to CAR-T and CAR-NK cell therapy from discovery to translation in the clinic from his work as a scientist and executive at Bellicum Pharmaceuticals. Previously he was an Assistant Professor at Baylor College of Medicine. He received his PhD in Molecular Biology from Princeton University and was a postdoctoral fellow at Stanford University School of Medicine.

HENRI BAYLE, PHD

CTO/CDO & CO-FOUNDER

Hank has extensive experience in the development of new approaches to CAR-T and CAR-NK cell therapy from discovery to translation in the clinic from his work as a scientist and executive at Bellicum Pharmaceuticals. Previously he was an Assistant Professor at Baylor College of Medicine. He received his PhD in Molecular Biology from Princeton University and was a postdoctoral fellow at Stanford University School of Medicine.

SIMON WAIN-HOBSON, DPHIL

CSO & CO-FOUNDER

Simon has published more than 230 papers in virology and cancer. Working with Luc Montagnier, he was first to sequence the genome of the AIDS virus HIV. He holds patents for the AIDS virus and 10 others. In addition to co-founding NKILT Therapeutics, he is a co-founder of Invectys, a US biotech company vaccinating against cancer. Simon received his DPhil in biochemistry from the University of Oxford and completed postdoctoral work in immunology at the Weizmann Institute. He was a tenured researcher, then professor, at the Pasteur Institute in Paris. He is an elected member of the European Molecular Biology Organization (EMBO), the Academia Europaea, and the US National Academy of Inventors. His accolades include Laureate, André Lwoff Prize; Laureate, Athena Prize, French Academy of Sciences; Chevalier de la Légion d’Honneur; Officier de la Légion d’Honneur; and Officer of the Order of the British Empire.

SIMON WAIN-HOBSON, DPHIL

CSO & CO-FOUNDER

Simon has published more than 230 papers in virology and cancer. Working with Luc Montagnier, he was first to sequence the genome of the AIDS virus HIV. He holds patents for the AIDS virus and 10 others. In addition to co-founding NKILT Therapeutics, he is a co-founder of Invectys, a US biotech company vaccinating against cancer. Simon received his DPhil in biochemistry from the University of Oxford and completed postdoctoral work in immunology at the Weizmann Institute. He was a tenured researcher, then professor, at the Pasteur Institute in Paris. He is an elected member of the European Molecular Biology Organization (EMBO), the Academia Europaea, and the US National Academy of Inventors. His accolades include Laureate, André Lwoff Prize; Laureate, Athena Prize, French Academy of Sciences; Officier de la Légion d’Honneur; and Officer of the Order of the British Empire.

INTERESTED IN HEARING MORE?

Provide your contact info and we will reach out.